EUVIMEDEUVIMED entdecken
Kohortenstudie

Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study

Robert Barrons iD, Edward Chiyaka iD

Journal of Pharmacy Practice · 2026

DOI: 10.1177/08971900251338904 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Pharmacy Practice, 2026. Verfasst von Robert Barrons und 1 weiteren Autor:innen. Beteiligte Einrichtung: Wingate University School of Pharmacy, Wingate, NC, USA. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Drug Monitoring, Staphylococcal Infections. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 2020 consensus guidelines for drug monitoring of vancomycin recommended AUC-guided dosing to reduce acute kidney injury (AKI) and improve clinical outcomes in patients with serious methicillin-resistant Staphylococcus aureus (MRSA) infections previously managed with trough concentrations of 15–20 mg/L.

Objectives

To determine if AUC-guided dosing of vancomycin reduces AKI and improves clinical outcomes including non-invasive infections with S. aureus compared with trough-only dosing broadened to concentrations of 10–20 mg/L.

Methods

A retrospective, single-center, cohort study was conducted over 12 months comparing Bayesian software-guided AUC-dosing with trough-only dosing. Information collected included patient demographics, co-morbidities, concurrent nephrotoxins, assessment measures of drug exposure, and patient outcomes. Nominal data were analyzed using the chi-square test, and continuous data using the independent t test.

Results

Based on the Kidney Disease Improving Global Outcomes (KDIGO) criteria, the incidence of AKI was 7.65% and 6.06% ( P = 0.56), among 183 patients in the AUC-guided and 165 subjects in the trough-only groups, respectively. Individuals in the trough-only group were younger, had fewer co-morbidities and admissions to the ICU. A lower incidence of AKI findings among trough-only subjects was likely a result of the duration of therapy (mean of 4.2 days), mean trough concentrations

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VancomycinAnti-Bacterial AgentsDrug MonitoringStaphylococcal InfectionsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedArea Under CurveAcute Kidney InjuryMethicillin-Resistant Staphylococcus aureusCohort StudiesDose-Response Relationship, DrugAdult

Stichwörter der Autor:innen

AUCacute kidney injury (AKI)nephrotoxicitytroughvancomycin dosing

Substanzen

VancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Wingate University School of Pharmacy, Wingate, NC, USA.

ORCID-Profile: Robert Barrons, Edward Chiyaka

Zitieren

APA

Barrons, R., & Chiyaka, E. (2026). Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900251338904

Vancouver

Barrons R, Chiyaka E. Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900251338904

BibTeX
@article{Barrons2026,
  author = {Barrons, Robert and Chiyaka, Edward},
  title = {Implementation of AUC-Guided Vancomycin Dosing: What Role Remains for Trough-Only Monitoring? A Retrospective, Cohort Study},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1177/08971900251338904}
}
Kostenlos starten →